AbbVie Closes Nimble Therapeutics Purchase-March 2024-www.financetom.com

AbbVie Closes Nimble Therapeutics Purchase

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

AbbVie Closes Nimble Therapeutics Purchase

Jan 23, 2025 7:10 AM

09:30 AM EST, 01/23/2025 (MT Newswires) -- AbbVie ( ABBV ) said Thursday it has closed the purchase of Nimble Therapeutics.

The company said last month that it would pay $200 million at closing, in addition to interim funding payments.

Previous page： Next page：

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

DocuSign's Profitability 'Bright Spot' in Fiscal Q2 Results, RBC Says

Sep 6, 2024

08:53 AM EDT, 09/06/2024 (MT Newswires) -- DocuSign's ( DOCU ) profitability was the bright spot in the company's decent fiscal Q2 results, RBC Capital Markets said in a note Thursday. The firm noted that DocuSign's ( DOCU ) roughly 32% operating margin beat market expectations by 480 basis points and was up by 750 basis points from a year...

Smartsheet in Favorable Position Due to 'Solid' Execution, ARR Growth in Fiscal Q2, Morgan Stanley Says

Sep 6, 2024

08:54 AM EDT, 09/06/2024 (MT Newswires) -- Smartsheet ( SMAR ) solid execution in fiscal Q2 continued with 120% growth seen in enterprise net revenue retention and robust large deal performance, analysts at Morgan Stanley said in a Friday note. The firm is also poised to continue posting positive earnings before interest and taxes and free cash flow revisions, the...